QUIDELORTHO AND BÜHLMANN LABORATORIES AG ANNOUNCE AVAILABILITY OF FECAL CALPROTECTIN (FCAL®) TURBO AND FECAL PANCREATIC ELASTASE (FPELA®) TURBO ASSAYS ON VITROS™ SYSTEMS AS A MICROTIP™ PARTNERSHIP ASSAY (MPA) - QuidelOrtho and BÜHLMANN Laboratories AG announced the availability of the fCAL® turbo and fPELA® turbo assays on VITROS™ Systems, enabling rapid and non-invasive diagnosis of IBD and pancreatic insufficiency.
BÜHLMANN Laboratories AG appoints Eric Hrimech as global Chief Commercial Officer (CCO) - BÜHLMANN Laboratories AG today announced the appointment of Eric Hrimech to the newly created position of global Chief Commercial Officer (CCO).

EPC 2025

Date: 2 – 5 July 2025
Location: Düsseldorf, Germany

57th Annual Meeting of the European Pancreatic Club

ADLM 2025

Date: 27 – 31 July 2025
Location: Chicago, IL, USA

Association for Diagnostics & Laboratory Medicine. Booth no. 4412

AMLI 2025

Date: 14 – 17 August 2025
Location: Minneapolis, MN, USA

38th annual meeting of the Association of Medical Laboratory Immunologists

SGKC /SSCC

Date: 26 August 2025
Location: Bern, Switzerland

Annual Meeting of the Swiss Society of Clinical Chemistry

SGM/SGI Annual Meeting

Date: 27 – 28 August 2025
Location: Interlaken, Switzerland

Swiss Society for Microbiology Annual Meeting 2025. Booth no. 1

DSA 2025

Date: 9 – 12 September 2025
Location: Dresden, Germany

Dresden Symposium on autoantibodies